CN102234601A - 低聚果糖、甘露糖及其衍生物在制备功能性低损伤酒和解酒制品中的应用 - Google Patents
低聚果糖、甘露糖及其衍生物在制备功能性低损伤酒和解酒制品中的应用 Download PDFInfo
- Publication number
- CN102234601A CN102234601A CN2010101586799A CN201010158679A CN102234601A CN 102234601 A CN102234601 A CN 102234601A CN 2010101586799 A CN2010101586799 A CN 2010101586799A CN 201010158679 A CN201010158679 A CN 201010158679A CN 102234601 A CN102234601 A CN 102234601A
- Authority
- CN
- China
- Prior art keywords
- wine
- seminose
- oligofructose
- mannose
- functional low
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014101 wine Nutrition 0.000 title claims abstract description 73
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000005715 Fructose Substances 0.000 title abstract description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 title abstract 5
- 230000006378 damage Effects 0.000 claims abstract description 30
- 239000000654 additive Substances 0.000 claims abstract description 24
- 230000000996 additive effect Effects 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 16
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 claims description 34
- 150000002703 mannose derivatives Chemical class 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 235000019991 rice wine Nutrition 0.000 claims description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 3
- 240000006365 Vitis vinifera Species 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- 235000013405 beer Nutrition 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 6
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 239000002778 food additive Substances 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- 241000700159 Rattus Species 0.000 description 28
- 208000025865 Ulcer Diseases 0.000 description 21
- 231100000397 ulcer Toxicity 0.000 description 21
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 20
- 210000001519 tissue Anatomy 0.000 description 20
- 210000002784 stomach Anatomy 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 12
- 230000000968 intestinal effect Effects 0.000 description 11
- 230000035622 drinking Effects 0.000 description 10
- 238000004043 dyeing Methods 0.000 description 10
- 230000002440 hepatic effect Effects 0.000 description 10
- 239000012188 paraffin wax Substances 0.000 description 10
- 239000003651 drinking water Substances 0.000 description 9
- 235000020188 drinking water Nutrition 0.000 description 9
- 101710088194 Dehydrogenase Proteins 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 210000000813 small intestine Anatomy 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 210000000416 exudates and transudate Anatomy 0.000 description 6
- 230000017074 necrotic cell death Effects 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 206010020718 hyperplasia Diseases 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000005229 liver cell Anatomy 0.000 description 5
- 210000004400 mucous membrane Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 210000001715 carotid artery Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 210000004969 inflammatory cell Anatomy 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010015719 Exsanguination Diseases 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 235000020035 kilju Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002497 edematous effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 230000007863 steatosis Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 206010013183 Dislocation of vertebra Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241000227425 Pieris rapae crucivora Species 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000005027 intestinal barrier Anatomy 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000004673 intestinal mucosal barrier function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
组别 | 实验开始前 | 实验开始后7天 | 实验开始后14天 |
干预组 | 38.35±2.37 | 35.58±4.42# | 35.01±3.49# |
模型对照组 | 37.36±2.38 | 19.44±2.53* | 18.59±2.69* |
正常对照组 | 37.82±2.99 | 37.65±3.48 | 37.73±2.49 |
组别 | 实验开始前 | 实验开始后7天 | 实验开始后14天 |
干预组 | 20.29±1.27 | 18.27±1.93 | 19.96±2.12 |
模型对照组 | 21.09±3.27 | 10.45±1.61 | 10.18±1.73* |
正常对照组 | 19.94±2.28 | 20.54±2.29 | 21.17±1.28 |
组别 | 乙醇脱氢酶含量(U/L) |
干预组 | 5.6±0.50**# |
模型对照组 | 3.5±0.35 |
正常对照组 | 6.0±0.27 |
组别 | 开始醉酒时间(min) | 持续醉酒时间(min) |
干预组 | 41.8±4.0* | 187±40.6* |
模型对照组 | 20.5±4.3 | 284±42.0 |
组别 | 体重减轻量(g) |
干预组 | -(3.65±1.28)* |
模型对照组 | -(20.56±2.69) |
组别 | 溃疡指数 | 溃疡抑制率(%) |
干预组 | 7.18±5.55 | 72.66 |
模型对照组 | 26.26±6.81 | - |
组别 | 开始醉酒时间(min) | 醉酒持续时间(min) |
干预组 | 45±5.0* | 136±19.4* |
模型对照组 | 22.5±5.3 | 280±22.5 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010158679.9A CN102234601B (zh) | 2010-04-23 | 2010-04-23 | 低聚果糖、甘露糖及其衍生物在制备功能性低损伤酒和解酒制品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010158679.9A CN102234601B (zh) | 2010-04-23 | 2010-04-23 | 低聚果糖、甘露糖及其衍生物在制备功能性低损伤酒和解酒制品中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102234601A true CN102234601A (zh) | 2011-11-09 |
CN102234601B CN102234601B (zh) | 2014-12-24 |
Family
ID=44885730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010158679.9A Expired - Fee Related CN102234601B (zh) | 2010-04-23 | 2010-04-23 | 低聚果糖、甘露糖及其衍生物在制备功能性低损伤酒和解酒制品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102234601B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104106830A (zh) * | 2014-08-04 | 2014-10-22 | 保龄宝生物股份有限公司 | 一种用于解酒的固体组合物 |
CN107668600A (zh) * | 2017-11-07 | 2018-02-09 | 美安康质量检测技术(上海)有限公司 | 一种解酒口服液的制备方法及解酒口服液 |
CN111671025A (zh) * | 2020-06-29 | 2020-09-18 | 华仁药业股份有限公司 | 一种解酒用糖电解质饮料及其制备方法 |
CN113667566A (zh) * | 2021-08-20 | 2021-11-19 | 山东沛学生物工程有限公司 | 一种含甘油葡萄糖苷的酒及甘油葡萄糖苷在酒中的应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1214365A (zh) * | 1997-10-13 | 1999-04-21 | 朱炜 | 新型保健酒 |
CN1371985A (zh) * | 2002-02-05 | 2002-10-02 | 中国科学院新疆化学研究所 | 一种含共轭亚油酸或共轭亚油酸衍生物的保健酒 |
CN1425750A (zh) * | 2003-01-13 | 2003-06-25 | 许立壮 | 一种大豆低聚糖保健啤酒及其配制方法 |
CN1534088A (zh) * | 2003-03-27 | 2004-10-06 | 中国人民解放军第三军医大学 | N-乙酰氨基葡萄糖作为添加剂在啤酒中的应用及包含n-乙酰氨基葡萄糖的啤酒 |
CN1742603A (zh) * | 2004-08-31 | 2006-03-08 | 柏大同 | 系列保健口香糖 |
WO2006033496A1 (en) * | 2004-09-24 | 2006-03-30 | Ben's Lab Co., Ltd. | Functional composition for the prevention and alleviation of hangover |
CN101356969A (zh) * | 2007-08-03 | 2009-02-04 | 杨品红 | 一种含有珍珠和葛根的系列保健食品及其制备方法 |
CN101401840A (zh) * | 2008-10-22 | 2009-04-08 | 中国林业科学研究院松花粉研究开发中心 | 一种用于解酒护肝的松花葛根片配方及其制备工艺 |
-
2010
- 2010-04-23 CN CN201010158679.9A patent/CN102234601B/zh not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1214365A (zh) * | 1997-10-13 | 1999-04-21 | 朱炜 | 新型保健酒 |
CN1371985A (zh) * | 2002-02-05 | 2002-10-02 | 中国科学院新疆化学研究所 | 一种含共轭亚油酸或共轭亚油酸衍生物的保健酒 |
CN1425750A (zh) * | 2003-01-13 | 2003-06-25 | 许立壮 | 一种大豆低聚糖保健啤酒及其配制方法 |
CN1534088A (zh) * | 2003-03-27 | 2004-10-06 | 中国人民解放军第三军医大学 | N-乙酰氨基葡萄糖作为添加剂在啤酒中的应用及包含n-乙酰氨基葡萄糖的啤酒 |
CN1742603A (zh) * | 2004-08-31 | 2006-03-08 | 柏大同 | 系列保健口香糖 |
WO2006033496A1 (en) * | 2004-09-24 | 2006-03-30 | Ben's Lab Co., Ltd. | Functional composition for the prevention and alleviation of hangover |
CN101356969A (zh) * | 2007-08-03 | 2009-02-04 | 杨品红 | 一种含有珍珠和葛根的系列保健食品及其制备方法 |
CN101401840A (zh) * | 2008-10-22 | 2009-04-08 | 中国林业科学研究院松花粉研究开发中心 | 一种用于解酒护肝的松花葛根片配方及其制备工艺 |
Non-Patent Citations (2)
Title |
---|
刘宗利等: "高纯度低聚果糖的生产及应用", 《山东食品发酵》 * |
项伟等: "我国解酒制品研制现状", 《食品科技》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104106830A (zh) * | 2014-08-04 | 2014-10-22 | 保龄宝生物股份有限公司 | 一种用于解酒的固体组合物 |
CN104106830B (zh) * | 2014-08-04 | 2015-11-18 | 保龄宝生物股份有限公司 | 一种用于解酒的固体组合物 |
CN107668600A (zh) * | 2017-11-07 | 2018-02-09 | 美安康质量检测技术(上海)有限公司 | 一种解酒口服液的制备方法及解酒口服液 |
CN111671025A (zh) * | 2020-06-29 | 2020-09-18 | 华仁药业股份有限公司 | 一种解酒用糖电解质饮料及其制备方法 |
CN111671025B (zh) * | 2020-06-29 | 2022-04-12 | 华仁药业股份有限公司 | 一种解酒用糖电解质饮料及其制备方法 |
CN113667566A (zh) * | 2021-08-20 | 2021-11-19 | 山东沛学生物工程有限公司 | 一种含甘油葡萄糖苷的酒及甘油葡萄糖苷在酒中的应用 |
CN113667566B (zh) * | 2021-08-20 | 2023-08-22 | 山东沛学生物工程有限公司 | 一种含甘油葡萄糖苷的酒及甘油葡萄糖苷在酒中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102234601B (zh) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102885310B (zh) | 一种辅助改善记忆的保健食品组合物及其制备方法 | |
CN102114044B (zh) | 一种人工加工熊胆粉及其制备方法 | |
CN102234601B (zh) | 低聚果糖、甘露糖及其衍生物在制备功能性低损伤酒和解酒制品中的应用 | |
Fan et al. | Effects of enteral nutrition with parenteral glutamine supplementation on the immunological function in septic rats | |
US20160263174A1 (en) | Method for treating inflammatory, allergic or asthma diseases, containing paprika extracts | |
JP2007526914A (ja) | 魚腥草と徳利苺の実の抽出物とそれらのアレルギー疾患予防及び治療用組成物(ExtractsofHouttuyniacordataandRubuscoreanusandtheircompositionforpreventingandtreatingallergicdiseases) | |
CN116948901A (zh) | 食窦魏斯氏菌d-2胞外多糖在抑制结肠癌细胞中的应用 | |
Sarkar et al. | Evaluation of in vitro anti diabetic activity of two mangrove plant extracts: Heritiera fomes and Sonneratia apetala | |
CN104288344A (zh) | 一种普洱茶提取物在制备调节肠道菌群及通便的药物或食品中的应用 | |
CN102198120B (zh) | 紫草萘醌类化合物的医药用途 | |
CN113521111B (zh) | 青春双歧杆菌在衰老延缓方面的应用 | |
CN103555527B (zh) | 蛇肽保健酒及其制备方法 | |
CN113908152A (zh) | 卡格列净及其类似物在制备防治雄性生殖功能障碍的药物中的用途 | |
CN108498546B (zh) | 一种预防或治疗溃疡性结肠炎癌变的中药组合物及应用 | |
CN102626418A (zh) | 一种鹿衔草多糖在制备增强免疫力药物和保健食品中的应用 | |
CN101524386B (zh) | 用于治疗脂肪肝的中药主要成分组方 | |
CN110123822A (zh) | 乳源低聚糖在制备用于通过缓解肠道缺氧损伤而治疗或预防nec的药物或食品中的用途 | |
CN105250247A (zh) | 虾青素在制备防治非酒精性脂肪性肝病药物中的应用 | |
CN103751257A (zh) | 氨基酸口服液及其制备方法 | |
CN114377041B (zh) | 鸦胆子油在制备药物中的用途 | |
CN117886788B (zh) | 新型稳态化锦葵花色苷衍生物及其制备方法和应用 | |
CN114190329B (zh) | 一种犬的急性肾衰竭模型建立的方法 | |
CN116196337A (zh) | 用于抗衰老的静脉给药制剂 | |
CN104257672A (zh) | 一种精氨酸双糖苷的新医疗用途 | |
Li et al. | Aldehyde Dehydrogenase 2 Interacts with PHB2 to Alleviate Renal Fibrosis and Ferroptosis in a Mitochondria-Dependent Manner: FR-PO1039 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: GUI TAIRONG Free format text: FORMER OWNER: NO.3 ARMY MEDICAL UNIV., PLA Effective date: 20121130 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Gui Tairong Inventor after: Xu Qiwang Inventor before: Liu Junkang Inventor before: Xu Qiwang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 400038 SHAPINGBA, CHONGQING TO: 401147 YUBEI, CHONGQING Free format text: CORRECT: INVENTOR; FROM: LIU JUNKANG XU QIWANG TO: GUI TAIRONG XU QIWANG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121130 Address after: 401147 Chongqing city Yubei District new irrigation Road No. 887 building 3 10-2 Applicant after: Gui Tairong Address before: Chongqing city Shapingba street 400038 gaotanyan No. 30 Applicant before: Third Military Medical University, Chinese People's Liberation Army |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170524 Address after: 400026, 1, building 53, 1 West Harbour Road, Jiangbei District, Chongqing, 5-1 Patentee after: Chongqing Xian Biotechnology Co., Ltd. Address before: 401147 Chongqing city Yubei District new irrigation Road No. 887 building 3 10-2 Patentee before: Gui Tairong |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141224 Termination date: 20200423 |